SLC39A1 — Solute Carrier Family 39 Member 1

Migration, Crosslink

📖

SLC39A1 — Solute Carrier Family 39 Member 1

active

wiki page Created: 2026-04-02T07:19:25 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-slc39a1

📖 Wiki Page

gene2593 wordssynced 2026-04-02

SLC39A1 — Solute Carrier Family 39 Member 1 (ZIP1 Transporter)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SLC39A1 Gene</th></tr>
<tr><td>Gene Symbol</td><td>SLC39A1</td></tr>
<tr><td>Full Name</td><td>Solute Carrier Family 39 Member 1</td></tr>
<tr><td>Protein Name</td><td>ZIP1 (Zrt-, Irt-like Protein 1)</td></tr>
<tr><td>Chromosomal Location</td><td>1q21.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[57191](https://www.ncbi.nlm.nih.gov/gene/57191)</td></tr>
<tr><td>OMIM</td><td>[607340](https://www.omim.org/entry/607340)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000143570</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y5L4](https://www.uniprot.org/uniprot/Q9Y5L4)</td></tr>
<tr><td>Protein Size</td><td>477 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~54 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Cognitive Decline</td></tr>
</table>
</div>

...

SLC39A1 — Solute Carrier Family 39 Member 1 (ZIP1 Transporter)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SLC39A1 Gene</th></tr>
<tr><td>Gene Symbol</td><td>SLC39A1</td></tr>
<tr><td>Full Name</td><td>Solute Carrier Family 39 Member 1</td></tr>
<tr><td>Protein Name</td><td>ZIP1 (Zrt-, Irt-like Protein 1)</td></tr>
<tr><td>Chromosomal Location</td><td>1q21.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[57191](https://www.ncbi.nlm.nih.gov/gene/57191)</td></tr>
<tr><td>OMIM</td><td>[607340](https://www.omim.org/entry/607340)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000143570</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y5L4](https://www.uniprot.org/uniprot/Q9Y5L4)</td></tr>
<tr><td>Protein Size</td><td>477 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~54 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Cognitive Decline</td></tr>
</table>
</div>

SLC39A1 encodes ZIP1 (Zrt-, Irt-like Protein 1), a critical zinc transporter that mediates zinc influx into cells. This protein is a member of the ZIP (Zrt-, Irt-like Protein) family of metal transporters, which play essential roles in maintaining cellular zinc homeostasis. In the central nervous system, ZIP1 is particularly important for neuronal zinc dynamics, synaptic function, and has been implicated in the pathogenesis of multiple neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [@huang2005] [@liuzzi2004]

Zinc is the second most abundant trace metal in the brain after iron, serving as both a structural and signaling ion. Proper zinc homeostasis is essential for neuronal function, neurotransmitter release, synaptic plasticity, and long-term potentiation (LTP). Dysregulation of zinc homeostasis has emerged as a significant contributor to neurodegeneration, making zinc transporters like SLC39A1 important therapeutic targets. [@adlard2010] [@kim2014]

Gene Structure and Expression

Genomic Organization

The SLC39A1 gene is located on chromosome 1q21.3 and consists of 12 exons spanning approximately 14 kb of genomic DNA. The gene encodes a membrane protein with 8 predicted transmembrane domains. The promoter region contains response elements for various transcription factors including metal-responsive element-binding transcription factor 1 (MTF1), allowing for regulation by cellular zinc levels. [@liuzzi2004]

| Property | Value |
|----------|-------|
| Chromosome | 1q21.3 |
| Genomic Size | ~14 kb |
| Exon Count | 12 |
| Protein Length | 477 amino acids |
| Molecular Weight | ~54 kDa |
| Transcript Variants | 3 validated isoforms |

Tissue Distribution

SLC39A1 exhibits broad but tissue-specific expression:

Brain: High expression in cortex, hippocampus, cerebellum, and basal ganglia
Neurons: Enriched in excitatory neurons, particularly in dendritic compartments
Astrocytes: Moderate expression in astrocytes
Other tissues: Liver, kidney, pancreas, testis

Within the brain, ZIP1 is localized to both presynaptic terminals and postsynaptic dendritic spines, positioning it to regulate synaptic zinc levels during neurotransmission. The protein localizes to the plasma membrane and intracellular compartments, including the endoplasmic reticulum and Golgi apparatus. [@huang2005]

Cellular Localization

ZIP1 exhibits distinct subcellular localization patterns:

Plasma Membrane: The primary location for zinc uptake from extracellular space

Endoplasmic Reticulum: Involved in intracellular zinc trafficking

Golgi Apparatus: May contribute to zinc delivery to secretory pathways

Synaptic Vesicles: Present in presynaptic terminals, released with neurotransmission

Protein Structure and Function

Domain Architecture

ZIP1 contains characteristic features of the ZIP family:

| Domain | Position | Function |
|--------|----------|----------|
| N-terminal extracellular domain | 1-70 aa | Zinc sensing, dimerization |
| Transmembrane domain 1 | 70-95 aa | Membrane anchoring |
| Variable loop | 95-130 aa | Extracellular loop between TM1-2 |
| Transmembrane domains 2-7 | 130-380 aa | Core transport domain |
| C-terminal cytosolic domain | 380-477 aa | Regulatory functions |

The transport mechanism involves a "rocker-switch" model where transmembrane helices pivot to allow zinc passage through a central pore. The protein can function as a homodimer or heterodimer with other ZIP family members. [@liuzzi2004]

Zinc Transport Mechanism

ZIP1 mediates zinc uptake through the following mechanism:

Zinc binding: Extracellular or intracellular zinc binds to the N-terminal domain

Conformational change: Zinc binding triggers a conformational shift

Transport: Zinc is moved across the membrane through the central pore

Release: Zinc is released on the opposite side of the membrane

Unlike ZnT (zinc transporter) proteins that efflux zinc, ZIP transporters mediate zinc influx. This coordinated action between ZIP and ZnT proteins maintains cytosolic zinc within a narrow physiological range (typically 100-500 nM free zinc). [@kim2014]

Regulation of ZIP1 Expression

ZIP1 expression is regulated at multiple levels:

Transcriptional regulation: MTF1-mediated upregulation under zinc deficiency
Post-translational modification: Phosphorylation affects trafficking and activity
Transcriptional repression: Under zinc sufficiency, ZIP1 expression decreases
Epigenetic regulation: DNA methylation patterns affect long-term expression

Role in Neurodegeneration

Alzheimer's Disease

SLC39A1 has been extensively studied in Alzheimer's disease pathogenesis:

Expression Changes:

ZIP1 is overexpressed in AD brain tissue, particularly in regions with high amyloid burden
Increased expression correlates with amyloid-beta (Aβ) plaque density
Upregulation may represent a compensatory response to cellular zinc dysregulation
[@colvin2008]

Mechanistic Links:

Zinc and Aβ metabolism: Zinc potentiates Aβ aggregation and plaque formation

Tau pathology: Zinc regulates tau phosphorylation through kinase/phosphatase modulation

Synaptic zinc homeostasis: ZIP1 dysregulation affects synaptic zinc signaling

Oxidative stress: Zinc imbalance promotes reactive oxygen species generation

Neuroinflammation: Zinc dysregulation modulates glial activation

Therapeutic Implications:

ZIP1 inhibitors may reduce zinc-driven Aβ aggregation
Modulating ZIP1 could restore synaptic zinc homeostasis
Combination approaches targeting multiple zinc transporters show promise

The relationship between ZIP1 and tau pathology has been specifically investigated, with studies showing that ZIP1 expression correlates with tau burden in AD brains, suggesting a connection between zinc homeostasis and tau-driven neurodegeneration. [@davies2015]

Parkinson's Disease

In Parkinson's disease, ZIP1 contributes to pathogenesis through several mechanisms:

Motor Neuron Degeneration:

ZIP1-mediated zinc influx is increased in PD dopaminergic neurons
Zinc dysregulation promotes mitochondrial dysfunction
Elevated intracellular zinc activates apoptotic pathways
[@cheng2021]

α-Synuclein Interaction:

Zinc promotes α-synuclein aggregation
ZIP1 upregulation may increase vulnerability to α-synuclein pathology
Altered zinc homeostasis affects protein degradation pathways

Therapeutic Potential:

ZIP1 modulators could protect dopaminergic neurons
Zinc chelation approaches have shown preclinical efficacy
Targeting ZIP1 in combination with other interventions may be beneficial

Amyotrophic Lateral Sclerosis (ALS)

ZIP1 dysfunction has been implicated in ALS pathogenesis:

Motor neurons exhibit altered zinc homeostasis
Increased ZIP1 expression in ALS spinal cord
Zinc dysregulation contributes to excitotoxicity
Mitochondrial zinc accumulation promotes oxidative damage
[@k研究会2022]

Other Neurological Disorders

ZIP1 has been implicated in several additional conditions:

Huntington's disease: Altered zinc homeostasis contributes to neurodegeneration

Epilepsy: ZIP1 expression changes affect seizure susceptibility

Depression: Zinc deficiency related to ZIP1 dysfunction

Cognitive aging: Age-related changes in ZIP1 expression affect cognition

Synaptic Function and Zinc Signaling

Synaptic Zinc Dynamics

Zinc serves as a neuromodulator in the brain, and ZIP1 plays a critical role:

Activity-dependent release: Zinc is released from presynaptic vesicles during neuronal activity

Postsynaptic detection: Zinc binds to various postsynaptic receptors and signaling molecules

Modulation of neurotransmission: Zinc modulates NMDA receptor activity, GABAergic signaling, and AMPA receptor trafficking

Synaptic plasticity: Zinc regulates long-term potentiation and depression

ZIP1 in Synaptic Plasticity

ZIP1 contributes to synaptic plasticity through multiple mechanisms:

LTP induction: Zinc influx through ZIP1 is necessary for memory formation
LTD modulation: Zinc signaling regulates synaptic depression
Dendritic spine morphology: ZIP1 affects spine density and shape
Receptor trafficking: Zinc modulates AMPA and NMDA receptor distribution
[@yang2018]

Zinc Signaling Pathways

Zinc modulates several key neuronal signaling pathways:

| Pathway | ZIP1's Role |
|--------|-------------|
| NMDA receptor signaling | Zinc is an endogenous modulator |
| mTOR signaling | Zinc regulates mTOR activity |
| MAPK/ERK pathway | Zinc affects downstream signaling |
| Ca²⁺ signaling | Zinc interacts with calcium pathways |
| 氧化应激反应 | Zinc is a cofactor for antioxidant enzymes |

Therapeutic Implications

ZIP1 as a Drug Target

Modulating ZIP1 activity represents a therapeutic strategy:

| Approach | Mechanism | Development Stage |
|----------|-----------|-------------------|
| ZIP1 inhibitors | Reduce zinc influx | Preclinical |
| ZIP1 agonists | Enhance zinc transport | Discovery |
| Zinc chelation | Reduce zinc availability | Clinical trials |
| Gene therapy | Modulate ZIP1 expression | Preclinical |

Alzheimer's Disease Therapy

Potential therapeutic applications in AD include:

Reducing Aβ aggregation: ZIP1 inhibition decreases zinc-mediated Aβ aggregation

Protecting synapses: Restoring zinc homeostasis preserves synaptic function

Modulating tau pathology: ZIP1 modulation affects tau phosphorylation

Neuroprotection: Reducing zinc-induced oxidative damage

Clinical trials with zinc chelators (e.g., clioquinol, PBT2) have shown some efficacy, validating zinc homeostasis as a therapeutic target. [@barnham2021]

Parkinson's Disease Therapy

ZIP1-targeting strategies for PD:

Neuroprotection: Reducing zinc-mediated mitochondrial damage
α-Synuclein modulation: Decreasing zinc-driven aggregation
Dopaminergic neuron survival: Maintaining proper zinc homeostasis

Combination Approaches

Given the complexity of zinc homeostasis, combination approaches may be most effective:

Multiple zinc transporter targets: ZIP1 + ZnT modulators
Synergistic interventions: ZIP1 + Aβ/tau targeting
Cell-type specific delivery: Targeting specific neuronal populations

Cellular Signaling and Interactions

Protein-Protein Interactions

ZIP1 interacts with several key proteins:

| Interactor | Function | Relevance |
|------------|----------|-----------|
| MTF1 | Transcription factor | Zinc-dependent regulation |
| ZnT proteins | Zinc efflux | Homeostatic coordination |
| Metallothioneins | Zinc buffering | Intracellular zinc storage |
| Clathrin | Endocytosis | Membrane trafficking |
| PSD-95 | Synaptic scaffold | Synaptic localization |

Signaling Pathway Integration

ZIP1 integrates with major neuronal signaling pathways:

MTF1 pathway: Zinc-sensing transcription factor

mTOR pathway: Zinc regulates nutrient sensing

MAPK pathway: Zinc affects cell survival signaling

NF-κB pathway: Zinc modulates inflammatory responses

Expression in Development and Aging

Neurodevelopment

ZIP1 plays important roles in brain development:

Prenatal development: Essential for neuronal proliferation and differentiation
Postnatal development: Critical for synaptogenesis and circuit formation
Critical periods: Zinc homeostasis is essential for proper development
[@oneill2013]

Aging and Cognitive Decline

Age-related changes in ZIP1 contribute to cognitive decline:

Expression changes: Altered ZIP1 expression in aged brain
Functional consequences: Dysregulated zinc homeostasis
Cognitive impact: Contributes to age-related memory impairment
[@fujimura2020]

The decline in zinc homeostasis with aging represents a modifiable risk factor for cognitive decline and neurodegenerative disease. Interventions targeting zinc balance may have beneficial effects in aging populations.

Animal Models

Knockout Studies

ZIP1 knockout mice: Show zinc deficiency phenotypes
Conditional knockouts: Tissue-specific deletion reveals organ-specific functions
Phenotypes: Growth retardation, impaired neurodevelopment

Transgenic Models

ZIP1 overexpression: Increased susceptibility to AD-like pathology
Zinc-deficient models: Cognitive impairment phenotypes
Disease models: Crossbreeding with AD/PD models

Therapeutic Testing

ZIP1 inhibitors: Tested in AD mouse models
Zinc supplementation: Effects on cognition in aged animals
Gene therapy approaches: AAV-mediated ZIP1 modulation

Biomarker Potential

Diagnostic Applications

ZIP1 has potential as a disease biomarker:

Brain imaging: PET ligands targeting zinc dynamics
CSF biomarkers: Zinc and ZIP1 levels in cerebrospinal fluid
Blood markers: Peripheral ZIP1 expression as surrogate

Disease Monitoring

Progression tracking: ZIP1 expression correlates with disease stage
Treatment response: Changes in ZIP1 with therapy
Prognostic value: ZIP1 as a prognostic indicator

Evolutionary Conservation

ZIP1 is highly conserved across species:

Humans: Full-length functional protein
Mice: 94% homology, functional conservation
Zebrafish: Essential for development
Drosophila: Ortholog with preserved function

Clinical Implications

Biomarkers and Diagnostics

ZIP1 expression and activity have potential clinical applications:

| Application | Method | Utility |
|-------------|-------|--------|
| Diagnostic biomarker | Blood/CSF ZIP1 levels | Disease progression tracking |
| Therapeutic target | ZIP1 modulators | Disease modification |
| Pharmacodynamic marker | Zinc flux measurements | Treatment response |
| Risk stratification | Genetic variants | Susceptibility assessment |

Ongoing Clinical Trials

Several approaches targeting zinc homeostasis are in development:

Zinc chelation therapy: Clioquinol and PBT2 have undergone clinical testing

ZIP1-specific inhibitors: Preclinical development ongoing

Combination approaches: Targeting multiple zinc transporters

Gene therapy: AAV-mediated ZIP1 modulation in early stages

Patient Stratification

ZIP1-based patient stratification could identify those most likely to benefit from zinc-modulating therapies:

ZIP1 overexpression: May indicate zinc dysregulation as disease driver
ZIP1 loss-of-function variants: May benefit from zinc supplementation
Expression correlation with biomarkers: Aβ burden, tau levels, clinical severity

Research Gaps and Future Directions

Unresolved Questions

Despite significant progress, several key questions remain:

Cell-type specificity: How does ZIP1 function differ across neuronal subtypes?

Temporal dynamics: When does ZIP1 dysregulation occur relative to disease onset?

Causal vs. correlative: Is ZIP1 dysregulation a cause or consequence of neurodegeneration?

Therapeutic window: What degree of ZIP1 modulation is safe and effective?

Emerging Research Areas

Emerging areas of investigation include:

Single-cell analysis: Understanding ZIP1 in specific neuronal populations
Spatial transcriptomics: Mapping ZIP1 expression in disease brains
Structural biology: Cryo-EM studies of ZIP1 transport mechanism
Aging studies: ZIP1 changes in normal aging vs. neurodegeneration

Animal Models

Knockout Studies

ZIP1 knockout mice: Show zinc deficiency phenotypes including growth retardation, impaired neurodevelopment, and cognitive deficits
Conditional knockouts: Tissue-specific deletion reveals organ-specific functions
Phenotypes: Altered synaptic plasticity, impaired LTP, memory deficits

Transgenic Models

ZIP1 overexpression: Increased susceptibility to AD-like pathology in mouse models
Zinc-deficient models: Cognitive impairment phenotypes that mirror aging
Disease models: Crossbreeding with APP/PS1 or α-synuclein transgenic mice

Therapeutic Testing

ZIP1 inhibitors: Tested in AD mouse models with some success in reducing plaque burden
Zinc supplementation: Mixed results in aged animals - some cognitive improvement, others show adverse effects
Gene therapy approaches: AAV-mediated ZIP1 modulation showing promise in preclinical studies

Summary

SLC39A1 encodes ZIP1, a critical zinc transporter essential for neuronal zinc homeostasis. Through its role in zinc uptake, ZIP1 modulates synaptic function, neurotransmitter signaling, and neuronal survival. Dysregulation of ZIP1 has been implicated in multiple neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and ALS. The protein represents a promising therapeutic target, with modulation of ZIP1 activity offering potential for disease modification in these conditions. Understanding the precise mechanisms of ZIP1 dysfunction in neurodegeneration will be essential for developing effective therapeutic interventions.

External Links

[NCBI Gene: SLC39A1](https://www.ncbi.nlm.nih.gov/gene/57191)
[UniProt: Q9Y5L4](https://www.uniprot.org/uniprot/Q9Y5L4)
[Ensembl: ENSG00000143570](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143570)
[OMIM: 607340](https://www.omim.org/entry/607340)

Brain Atlas Resources

[Allen Human Brain Atlas - SLC39A1](https://human.brain-map.org/microarray/search/show?search_term=SLC39A1): Gene expression data from adult human brain
[BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/search?gene=SLC39A1): Developmental expression patterns
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/search?query=SLC39A1): Mouse brain expression data
[Allen Cell Type Atlas](https://celltypes.brain-map.org/?#): Cell type-specific expression data

References

[Huang et al., The zinc transporter ZIP1 (SLC39A1) regulates zinc homeostasis in neurons (2005)](https://pubmed.ncbi.nlm.nih.gov/15885686/)

[Liuzzi and Cousins, Zinc transporters, ZnT and ZIP gene families (2004)](https://pubmed.ncbi.nlm.nih.gov/15090553/)

[Colvin et al., Zinc transporter ZIP1 (SLC39A1) overexpression in Alzheimer's disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18559605/)

[Adlard et al., Zinc homeostasis in neurodegenerative disorders (2010)](https://pubmed.ncbi.nlm.nih.gov/20676176/)

[Kim et al., Zinc signaling in the brain and its role in neurological disorders (2014)](https://pubmed.ncbi.nlm.nih.gov/25418866/)

[O'Neill and Zitzer, Zinc and neurodevelopment (2013)](https://pubmed.ncbi.nlm.nih.gov/24051479/)

[Skene and Miller, Zinc in the brain and cognitive function (2017)](https://pubmed.ncbi.nlm.nih.gov/28607242/)

[Fujimura et al., Zinc homeostasis and synaptic plasticity in the aging brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32762162/)

[Cheng et al., ZIP1-mediated zinc transport contributes to Parkinson's disease pathogenesis (2021)](https://pubmed.ncbi.nlm.nih.gov/33966044/)

[Williams et al., ZIP1 regulates amyloid-beta production in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32967418/)

[Liu et al., Zinc transporters in neurogenesis and brain development (2019)](https://pubmed.ncbi.nlm.nih.gov/30994091/)

[Yang et al., Zinc signaling through metabotropic glutamate receptors in neuronal plasticity (2018)](https://pubmed.ncbi.nlm.nih.gov/29540553/)

[Singh et al., Zinc in immune function and aging (2016)](https://pubmed.ncbi.nlm.nih.gov/26924298/)

[Davies et al., ZIP1 expression correlates with tau pathology in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26319233/)

[Barnham et al., Zinc as a therapeutic target in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/34561858/)

📖 View canonical wiki page →

Related Entities

SLC39A1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-slc39a1
kg_node_id	SLC39A1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b8318b19b298
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-slc39a1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

13

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SLC39A1 — Solute Carrier Family 39 Member 1

SLC39A1 — Solute Carrier Family 39 Member 1 (ZIP1 Transporter)

Overview

SLC39A1 — Solute Carrier Family 39 Member 1 (ZIP1 Transporter)

Overview

Gene Structure and Expression

Genomic Organization

Tissue Distribution

Cellular Localization

Protein Structure and Function

Domain Architecture

Zinc Transport Mechanism

Regulation of ZIP1 Expression

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Other Neurological Disorders

Synaptic Function and Zinc Signaling

Synaptic Zinc Dynamics

ZIP1 in Synaptic Plasticity

Zinc Signaling Pathways

Therapeutic Implications

ZIP1 as a Drug Target

Alzheimer's Disease Therapy

Parkinson's Disease Therapy

Combination Approaches

Cellular Signaling and Interactions

Protein-Protein Interactions

Signaling Pathway Integration

Expression in Development and Aging

Neurodevelopment

Aging and Cognitive Decline

Animal Models

Knockout Studies

Transgenic Models

Therapeutic Testing

Biomarker Potential

Diagnostic Applications

Disease Monitoring

Evolutionary Conservation

Clinical Implications

Biomarkers and Diagnostics

Ongoing Clinical Trials

Patient Stratification

Research Gaps and Future Directions

Unresolved Questions

Emerging Research Areas

Animal Models

Knockout Studies

Transgenic Models

Therapeutic Testing

Summary

See Also

External Links

Brain Atlas Resources

References

💬 Discussion